Quest Diagnostics temporarily suspended access to several systems following a cyberattack involving patient information.
Quest Diagnostics Inc. (DGX) News
Latest headlines that mention DGX, newest first · each headline opens the original publisher
- Last price
- $243.43
- Day change
- +0.06%
- Next earnings
- —
DGX headlines
last 30 daysAutomation and direct-to-consumer expansion are offsetting wage inflation and Medicare reimbursement pressure, the dual challenge facing diagnostics providers.
Revenue grew 10% as automation and AI boosted margins amid regulatory headwinds.
Quest Diagnostics did "good enough" against an "increasingly high bar," an analyst said Thursday. Quest stock wavered and closed in the green. The post Was Quest's 'Good Enough' Third Quarter Actually Good Enough? appeared first on Investor's Business Daily .
DGX news alerts
Get an alert by email or push when a new headline mentions DGX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.